Serum Institute gets DCGI nod for clinical trials of Oxford vax
Published By : Prameya News Bureau | August 03, 2020 IST
Share
New Delhi, Aug 3: The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India.The SII received approval by the India's top drug regulator on Sunday after a thorough evaluation based on the recommendations of the Subject Expert Committee on COVID-19.In a statement, the Health Ministry said, "Drugs Controller General of India has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India."The institute had submitted a application seeking permission for conducting the trial in July last week.The vaccine candidate is in the midst of Phase II and III clinical trials in the UK, Phase III trials in Brazil, and Phase I and II clinical trials in South Africa. (IANS)
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
Patient awareness and interaction programme marks World Liver Day at AIIMS Bhubaneswar
Rising cases of pediatric liver issues linked to junk food epidemic
Vital organ, vital importance: Why maintaining liver health matters
World Liver Day 2024: These factors contribute to liver damage
Nestle baby food sugar study causes concern in India, Nestle India's shares fall
World Voice Day observed at SUM Phulnakhara Campus
Cadaveric kidney transplant performed at SCB Hospital
Closure of regn counter sparks tension at Bhubaneswar AIIMS
From pain to comfort: Discover the doctor who cares for your bad back
Boys born to mothers with HIV more vulnerable to death in infancy
World Hemophilia Day: Solidarity for people living with rare genetic disorder
AIIMS Bhubaneswar launches advanced Artificial Urinary Sphincter(AUS) implantation service
Indians up their spending on dieticians by 125 pc in FY24: Report
Zomato introduces 'large order fleet' for gatherings of up to 50 people
Critical patient successfully treated at SUM Phulnakhara campus
Nasal cells shield kids from Covid, Study finds
Scientists decode how exercise can reverse ageing
Remove Bournvita from category of ‘health drinks’: Govt tells e-commerce firms
Menstruation signifies femininity and fertility, not impurity
44% Odisha people never check blood pressure: ICMY study